Global ERA Drugs Market Growth 2026-2032
The global ERA Drugs market size is predicted to grow from US$ 3010 million in 2025 to US$ 6327 million in 2032; it is expected to grow at a CAGR of 11.4% from 2026 to 2032.
ERAs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They work by blocking the binding of endothelin (a powerful vasoconstrictor) to its receptors, thereby relaxing blood vessels, lowering blood pressure, and improving blood flow.
United States market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key ERA Drugs players cover Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?ERA Drugs Industry Forecast? looks at past sales and reviews total world ERA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected ERA Drugs sales for 2026 through 2032. With ERA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ERA Drugs industry.
This Insight Report provides a comprehensive analysis of the global ERA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ERA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global ERA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ERA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ERA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of ERA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global ERA Drugs market?
What factors are driving ERA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ERA Drugs market opportunities vary by end market size?
How does ERA Drugs break out by Type, by Application?
ERAs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They work by blocking the binding of endothelin (a powerful vasoconstrictor) to its receptors, thereby relaxing blood vessels, lowering blood pressure, and improving blood flow.
United States market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for ERA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key ERA Drugs players cover Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?ERA Drugs Industry Forecast? looks at past sales and reviews total world ERA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected ERA Drugs sales for 2026 through 2032. With ERA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ERA Drugs industry.
This Insight Report provides a comprehensive analysis of the global ERA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ERA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global ERA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ERA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ERA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of ERA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bosentan
- Ambrisentan
- Macitentan
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Zhengda Tianqing
- Sinotherapeutics
- Qilu Pharmaceutical
- Hangzhou Zhongmei Huadong Pharmaceutical
- Shanghai Xudong Haipu Pharmaceutical
- Shanghai Pharmaceutical Group
- Jiangsu Yunyang Group Pharmaceutical
- Mylan
- Teva
- Dr. Reddy's Laboratories
- Gilead Sciences
- United Therapeutics
What is the 10-year outlook for the global ERA Drugs market?
What factors are driving ERA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ERA Drugs market opportunities vary by end market size?
How does ERA Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ERA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for ERA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for ERA Drugs by Country/Region, 2021, 2025 & 2032
2.2 ERA Drugs Segment by Type
2.2.1 Bosentan
2.2.2 Ambrisentan
2.2.3 Macitentan
2.2.4 ERA Drugs Sales by Type
2.2.4.1 Global ERA Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global ERA Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global ERA Drugs Sale Price by Type (2021-2026)
2.3 ERA Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 ERA Drugs Sales by Application
2.3.4.1 Global ERA Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global ERA Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global ERA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global ERA Drugs Breakdown Data by Company
3.1.1 Global ERA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global ERA Drugs Sales Market Share by Company (2021-2026)
3.2 Global ERA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global ERA Drugs Revenue by Company (2021-2026)
3.2.2 Global ERA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global ERA Drugs Sale Price by Company
3.4 Key Manufacturers ERA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ERA Drugs Product Location Distribution
3.4.2 Players ERA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic ERA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global ERA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global ERA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic ERA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global ERA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global ERA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas ERA Drugs Sales Growth
4.4 APAC ERA Drugs Sales Growth
4.5 Europe ERA Drugs Sales Growth
4.6 Middle East & Africa ERA Drugs Sales Growth
5 AMERICAS
5.1 Americas ERA Drugs Sales by Country
5.1.1 Americas ERA Drugs Sales by Country (2021-2026)
5.1.2 Americas ERA Drugs Revenue by Country (2021-2026)
5.2 Americas ERA Drugs Sales by Type (2021-2026)
5.3 Americas ERA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ERA Drugs Sales by Region
6.1.1 APAC ERA Drugs Sales by Region (2021-2026)
6.1.2 APAC ERA Drugs Revenue by Region (2021-2026)
6.2 APAC ERA Drugs Sales by Type (2021-2026)
6.3 APAC ERA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe ERA Drugs by Country
7.1.1 Europe ERA Drugs Sales by Country (2021-2026)
7.1.2 Europe ERA Drugs Revenue by Country (2021-2026)
7.2 Europe ERA Drugs Sales by Type (2021-2026)
7.3 Europe ERA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ERA Drugs by Country
8.1.1 Middle East & Africa ERA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa ERA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa ERA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa ERA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ERA Drugs
10.3 Manufacturing Process Analysis of ERA Drugs
10.4 Industry Chain Structure of ERA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ERA Drugs Distributors
11.3 ERA Drugs Customer
12 WORLD FORECAST REVIEW FOR ERA DRUGS BY GEOGRAPHIC REGION
12.1 Global ERA Drugs Market Size Forecast by Region
12.1.1 Global ERA Drugs Forecast by Region (2027-2032)
12.1.2 Global ERA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global ERA Drugs Forecast by Type (2027-2032)
12.7 Global ERA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson ERA Drugs Product Portfolios and Specifications
13.1.3 Johnson & Johnson ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Zhengda Tianqing
13.2.1 Zhengda Tianqing Company Information
13.2.2 Zhengda Tianqing ERA Drugs Product Portfolios and Specifications
13.2.3 Zhengda Tianqing ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zhengda Tianqing Main Business Overview
13.2.5 Zhengda Tianqing Latest Developments
13.3 Sinotherapeutics
13.3.1 Sinotherapeutics Company Information
13.3.2 Sinotherapeutics ERA Drugs Product Portfolios and Specifications
13.3.3 Sinotherapeutics ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinotherapeutics Main Business Overview
13.3.5 Sinotherapeutics Latest Developments
13.4 Qilu Pharmaceutical
13.4.1 Qilu Pharmaceutical Company Information
13.4.2 Qilu Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.4.3 Qilu Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Qilu Pharmaceutical Main Business Overview
13.4.5 Qilu Pharmaceutical Latest Developments
13.5 Hangzhou Zhongmei Huadong Pharmaceutical
13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.6 Shanghai Xudong Haipu Pharmaceutical
13.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.6.2 Shanghai Xudong Haipu Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.6.3 Shanghai Xudong Haipu Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.6.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.7 Shanghai Pharmaceutical Group
13.7.1 Shanghai Pharmaceutical Group Company Information
13.7.2 Shanghai Pharmaceutical Group ERA Drugs Product Portfolios and Specifications
13.7.3 Shanghai Pharmaceutical Group ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Pharmaceutical Group Main Business Overview
13.7.5 Shanghai Pharmaceutical Group Latest Developments
13.8 Jiangsu Yunyang Group Pharmaceutical
13.8.1 Jiangsu Yunyang Group Pharmaceutical Company Information
13.8.2 Jiangsu Yunyang Group Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.8.3 Jiangsu Yunyang Group Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangsu Yunyang Group Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yunyang Group Pharmaceutical Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan ERA Drugs Product Portfolios and Specifications
13.9.3 Mylan ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva ERA Drugs Product Portfolios and Specifications
13.10.3 Teva ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories ERA Drugs Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Gilead Sciences
13.12.1 Gilead Sciences Company Information
13.12.2 Gilead Sciences ERA Drugs Product Portfolios and Specifications
13.12.3 Gilead Sciences ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Gilead Sciences Main Business Overview
13.12.5 Gilead Sciences Latest Developments
13.13 United Therapeutics
13.13.1 United Therapeutics Company Information
13.13.2 United Therapeutics ERA Drugs Product Portfolios and Specifications
13.13.3 United Therapeutics ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 United Therapeutics Main Business Overview
13.13.5 United Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ERA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for ERA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for ERA Drugs by Country/Region, 2021, 2025 & 2032
2.2 ERA Drugs Segment by Type
2.2.1 Bosentan
2.2.2 Ambrisentan
2.2.3 Macitentan
2.2.4 ERA Drugs Sales by Type
2.2.4.1 Global ERA Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global ERA Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global ERA Drugs Sale Price by Type (2021-2026)
2.3 ERA Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 ERA Drugs Sales by Application
2.3.4.1 Global ERA Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global ERA Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global ERA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global ERA Drugs Breakdown Data by Company
3.1.1 Global ERA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global ERA Drugs Sales Market Share by Company (2021-2026)
3.2 Global ERA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global ERA Drugs Revenue by Company (2021-2026)
3.2.2 Global ERA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global ERA Drugs Sale Price by Company
3.4 Key Manufacturers ERA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ERA Drugs Product Location Distribution
3.4.2 Players ERA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic ERA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global ERA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global ERA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic ERA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global ERA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global ERA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas ERA Drugs Sales Growth
4.4 APAC ERA Drugs Sales Growth
4.5 Europe ERA Drugs Sales Growth
4.6 Middle East & Africa ERA Drugs Sales Growth
5 AMERICAS
5.1 Americas ERA Drugs Sales by Country
5.1.1 Americas ERA Drugs Sales by Country (2021-2026)
5.1.2 Americas ERA Drugs Revenue by Country (2021-2026)
5.2 Americas ERA Drugs Sales by Type (2021-2026)
5.3 Americas ERA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ERA Drugs Sales by Region
6.1.1 APAC ERA Drugs Sales by Region (2021-2026)
6.1.2 APAC ERA Drugs Revenue by Region (2021-2026)
6.2 APAC ERA Drugs Sales by Type (2021-2026)
6.3 APAC ERA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe ERA Drugs by Country
7.1.1 Europe ERA Drugs Sales by Country (2021-2026)
7.1.2 Europe ERA Drugs Revenue by Country (2021-2026)
7.2 Europe ERA Drugs Sales by Type (2021-2026)
7.3 Europe ERA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ERA Drugs by Country
8.1.1 Middle East & Africa ERA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa ERA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa ERA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa ERA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ERA Drugs
10.3 Manufacturing Process Analysis of ERA Drugs
10.4 Industry Chain Structure of ERA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ERA Drugs Distributors
11.3 ERA Drugs Customer
12 WORLD FORECAST REVIEW FOR ERA DRUGS BY GEOGRAPHIC REGION
12.1 Global ERA Drugs Market Size Forecast by Region
12.1.1 Global ERA Drugs Forecast by Region (2027-2032)
12.1.2 Global ERA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global ERA Drugs Forecast by Type (2027-2032)
12.7 Global ERA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson ERA Drugs Product Portfolios and Specifications
13.1.3 Johnson & Johnson ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Zhengda Tianqing
13.2.1 Zhengda Tianqing Company Information
13.2.2 Zhengda Tianqing ERA Drugs Product Portfolios and Specifications
13.2.3 Zhengda Tianqing ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zhengda Tianqing Main Business Overview
13.2.5 Zhengda Tianqing Latest Developments
13.3 Sinotherapeutics
13.3.1 Sinotherapeutics Company Information
13.3.2 Sinotherapeutics ERA Drugs Product Portfolios and Specifications
13.3.3 Sinotherapeutics ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinotherapeutics Main Business Overview
13.3.5 Sinotherapeutics Latest Developments
13.4 Qilu Pharmaceutical
13.4.1 Qilu Pharmaceutical Company Information
13.4.2 Qilu Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.4.3 Qilu Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Qilu Pharmaceutical Main Business Overview
13.4.5 Qilu Pharmaceutical Latest Developments
13.5 Hangzhou Zhongmei Huadong Pharmaceutical
13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.6 Shanghai Xudong Haipu Pharmaceutical
13.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.6.2 Shanghai Xudong Haipu Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.6.3 Shanghai Xudong Haipu Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.6.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.7 Shanghai Pharmaceutical Group
13.7.1 Shanghai Pharmaceutical Group Company Information
13.7.2 Shanghai Pharmaceutical Group ERA Drugs Product Portfolios and Specifications
13.7.3 Shanghai Pharmaceutical Group ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Pharmaceutical Group Main Business Overview
13.7.5 Shanghai Pharmaceutical Group Latest Developments
13.8 Jiangsu Yunyang Group Pharmaceutical
13.8.1 Jiangsu Yunyang Group Pharmaceutical Company Information
13.8.2 Jiangsu Yunyang Group Pharmaceutical ERA Drugs Product Portfolios and Specifications
13.8.3 Jiangsu Yunyang Group Pharmaceutical ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangsu Yunyang Group Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yunyang Group Pharmaceutical Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan ERA Drugs Product Portfolios and Specifications
13.9.3 Mylan ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva ERA Drugs Product Portfolios and Specifications
13.10.3 Teva ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories ERA Drugs Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Gilead Sciences
13.12.1 Gilead Sciences Company Information
13.12.2 Gilead Sciences ERA Drugs Product Portfolios and Specifications
13.12.3 Gilead Sciences ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Gilead Sciences Main Business Overview
13.12.5 Gilead Sciences Latest Developments
13.13 United Therapeutics
13.13.1 United Therapeutics Company Information
13.13.2 United Therapeutics ERA Drugs Product Portfolios and Specifications
13.13.3 United Therapeutics ERA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 United Therapeutics Main Business Overview
13.13.5 United Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. ERA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. ERA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bosentan
Table 4. Major Players of Ambrisentan
Table 5. Major Players of Macitentan
Table 6. Global ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global ERA Drugs Sales Market Share by Type (2021-2026)
Table 8. Global ERA Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global ERA Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global ERA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global ERA Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global ERA Drugs Sale Market Share by Application (2021-2026)
Table 13. Global ERA Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global ERA Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global ERA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global ERA Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global ERA Drugs Sales Market Share by Company (2021-2026)
Table 18. Global ERA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global ERA Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global ERA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers ERA Drugs Producing Area Distribution and Sales Area
Table 22. Players ERA Drugs Products Offered
Table 23. ERA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global ERA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global ERA Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global ERA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global ERA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global ERA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global ERA Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global ERA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global ERA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas ERA Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas ERA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC ERA Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC ERA Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC ERA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe ERA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa ERA Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of ERA Drugs
Table 53. Key Market Challenges & Risks of ERA Drugs
Table 54. Key Industry Trends of ERA Drugs
Table 55. ERA Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. ERA Drugs Distributors List
Table 58. ERA Drugs Customer List
Table 59. Global ERA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global ERA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas ERA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC ERA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC ERA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe ERA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa ERA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global ERA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global ERA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global ERA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global ERA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Johnson & Johnson Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson ERA Drugs Product Portfolios and Specifications
Table 75. Johnson & Johnson ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Zhengda Tianqing Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Zhengda Tianqing ERA Drugs Product Portfolios and Specifications
Table 80. Zhengda Tianqing ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Zhengda Tianqing Main Business
Table 82. Zhengda Tianqing Latest Developments
Table 83. Sinotherapeutics Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Sinotherapeutics ERA Drugs Product Portfolios and Specifications
Table 85. Sinotherapeutics ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sinotherapeutics Main Business
Table 87. Sinotherapeutics Latest Developments
Table 88. Qilu Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qilu Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 90. Qilu Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Qilu Pharmaceutical Main Business
Table 92. Qilu Pharmaceutical Latest Developments
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 95. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 97. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 98. Shanghai Xudong Haipu Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 100. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 102. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 103. Shanghai Pharmaceutical Group Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Pharmaceutical Group ERA Drugs Product Portfolios and Specifications
Table 105. Shanghai Pharmaceutical Group ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shanghai Pharmaceutical Group Main Business
Table 107. Shanghai Pharmaceutical Group Latest Developments
Table 108. Jiangsu Yunyang Group Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 110. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Jiangsu Yunyang Group Pharmaceutical Main Business
Table 112. Jiangsu Yunyang Group Pharmaceutical Latest Developments
Table 113. Mylan Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan ERA Drugs Product Portfolios and Specifications
Table 115. Mylan ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Teva Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva ERA Drugs Product Portfolios and Specifications
Table 120. Teva ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Teva Main Business
Table 122. Teva Latest Developments
Table 123. Dr. Reddy's Laboratories Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Dr. Reddy's Laboratories ERA Drugs Product Portfolios and Specifications
Table 125. Dr. Reddy's Laboratories ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Dr. Reddy's Laboratories Main Business
Table 127. Dr. Reddy's Laboratories Latest Developments
Table 128. Gilead Sciences Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Gilead Sciences ERA Drugs Product Portfolios and Specifications
Table 130. Gilead Sciences ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Gilead Sciences Main Business
Table 132. Gilead Sciences Latest Developments
Table 133. United Therapeutics Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. United Therapeutics ERA Drugs Product Portfolios and Specifications
Table 135. United Therapeutics ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. United Therapeutics Main Business
Table 137. United Therapeutics Latest Developments
Table 1. ERA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. ERA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bosentan
Table 4. Major Players of Ambrisentan
Table 5. Major Players of Macitentan
Table 6. Global ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global ERA Drugs Sales Market Share by Type (2021-2026)
Table 8. Global ERA Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global ERA Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global ERA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global ERA Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global ERA Drugs Sale Market Share by Application (2021-2026)
Table 13. Global ERA Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global ERA Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global ERA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global ERA Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global ERA Drugs Sales Market Share by Company (2021-2026)
Table 18. Global ERA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global ERA Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global ERA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers ERA Drugs Producing Area Distribution and Sales Area
Table 22. Players ERA Drugs Products Offered
Table 23. ERA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global ERA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global ERA Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global ERA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global ERA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global ERA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global ERA Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global ERA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global ERA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas ERA Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas ERA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC ERA Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC ERA Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC ERA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe ERA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa ERA Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa ERA Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa ERA Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa ERA Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of ERA Drugs
Table 53. Key Market Challenges & Risks of ERA Drugs
Table 54. Key Industry Trends of ERA Drugs
Table 55. ERA Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. ERA Drugs Distributors List
Table 58. ERA Drugs Customer List
Table 59. Global ERA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global ERA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas ERA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC ERA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC ERA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe ERA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa ERA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa ERA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global ERA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global ERA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global ERA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global ERA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Johnson & Johnson Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson ERA Drugs Product Portfolios and Specifications
Table 75. Johnson & Johnson ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Zhengda Tianqing Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Zhengda Tianqing ERA Drugs Product Portfolios and Specifications
Table 80. Zhengda Tianqing ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Zhengda Tianqing Main Business
Table 82. Zhengda Tianqing Latest Developments
Table 83. Sinotherapeutics Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Sinotherapeutics ERA Drugs Product Portfolios and Specifications
Table 85. Sinotherapeutics ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sinotherapeutics Main Business
Table 87. Sinotherapeutics Latest Developments
Table 88. Qilu Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qilu Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 90. Qilu Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Qilu Pharmaceutical Main Business
Table 92. Qilu Pharmaceutical Latest Developments
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 95. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 97. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 98. Shanghai Xudong Haipu Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 100. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 102. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 103. Shanghai Pharmaceutical Group Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Pharmaceutical Group ERA Drugs Product Portfolios and Specifications
Table 105. Shanghai Pharmaceutical Group ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shanghai Pharmaceutical Group Main Business
Table 107. Shanghai Pharmaceutical Group Latest Developments
Table 108. Jiangsu Yunyang Group Pharmaceutical Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Product Portfolios and Specifications
Table 110. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Jiangsu Yunyang Group Pharmaceutical Main Business
Table 112. Jiangsu Yunyang Group Pharmaceutical Latest Developments
Table 113. Mylan Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan ERA Drugs Product Portfolios and Specifications
Table 115. Mylan ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Teva Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva ERA Drugs Product Portfolios and Specifications
Table 120. Teva ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Teva Main Business
Table 122. Teva Latest Developments
Table 123. Dr. Reddy's Laboratories Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Dr. Reddy's Laboratories ERA Drugs Product Portfolios and Specifications
Table 125. Dr. Reddy's Laboratories ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Dr. Reddy's Laboratories Main Business
Table 127. Dr. Reddy's Laboratories Latest Developments
Table 128. Gilead Sciences Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Gilead Sciences ERA Drugs Product Portfolios and Specifications
Table 130. Gilead Sciences ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Gilead Sciences Main Business
Table 132. Gilead Sciences Latest Developments
Table 133. United Therapeutics Basic Information, ERA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. United Therapeutics ERA Drugs Product Portfolios and Specifications
Table 135. United Therapeutics ERA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. United Therapeutics Main Business
Table 137. United Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of ERA Drugs
Figure 2. ERA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ERA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global ERA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. ERA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. ERA Drugs Sales Market Share by Country/Region (2025)
Figure 10. ERA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bosentan
Figure 12. Product Picture of Ambrisentan
Figure 13. Product Picture of Macitentan
Figure 14. Global ERA Drugs Sales Market Share by Type in 2026
Figure 15. Global ERA Drugs Revenue Market Share by Type (2021-2026)
Figure 16. ERA Drugs Consumed in Hospital
Figure 17. Global ERA Drugs Market: Hospital (2021-2026) & (K Units)
Figure 18. ERA Drugs Consumed in Clinic
Figure 19. Global ERA Drugs Market: Clinic (2021-2026) & (K Units)
Figure 20. ERA Drugs Consumed in Other
Figure 21. Global ERA Drugs Market: Other (2021-2026) & (K Units)
Figure 22. Global ERA Drugs Sale Market Share by Application (2025)
Figure 23. Global ERA Drugs Revenue Market Share by Application in 2026
Figure 24. ERA Drugs Sales by Company in 2026 (K Units)
Figure 25. Global ERA Drugs Sales Market Share by Company in 2026
Figure 26. ERA Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global ERA Drugs Revenue Market Share by Company in 2026
Figure 28. Global ERA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global ERA Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas ERA Drugs Sales 2021-2026 (K Units)
Figure 31. Americas ERA Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC ERA Drugs Sales 2021-2026 (K Units)
Figure 33. APAC ERA Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe ERA Drugs Sales 2021-2026 (K Units)
Figure 35. Europe ERA Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa ERA Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa ERA Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas ERA Drugs Sales Market Share by Country in 2026
Figure 39. Americas ERA Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas ERA Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas ERA Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC ERA Drugs Sales Market Share by Region in 2026
Figure 47. APAC ERA Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC ERA Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC ERA Drugs Sales Market Share by Application (2021-2026)
Figure 50. China ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe ERA Drugs Sales Market Share by Country in 2026
Figure 58. Europe ERA Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe ERA Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe ERA Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa ERA Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa ERA Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa ERA Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of ERA Drugs in 2026
Figure 75. Manufacturing Process Analysis of ERA Drugs
Figure 76. Industry Chain Structure of ERA Drugs
Figure 77. Channels of Distribution
Figure 78. Global ERA Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global ERA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global ERA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global ERA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global ERA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global ERA Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of ERA Drugs
Figure 2. ERA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ERA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global ERA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. ERA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. ERA Drugs Sales Market Share by Country/Region (2025)
Figure 10. ERA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bosentan
Figure 12. Product Picture of Ambrisentan
Figure 13. Product Picture of Macitentan
Figure 14. Global ERA Drugs Sales Market Share by Type in 2026
Figure 15. Global ERA Drugs Revenue Market Share by Type (2021-2026)
Figure 16. ERA Drugs Consumed in Hospital
Figure 17. Global ERA Drugs Market: Hospital (2021-2026) & (K Units)
Figure 18. ERA Drugs Consumed in Clinic
Figure 19. Global ERA Drugs Market: Clinic (2021-2026) & (K Units)
Figure 20. ERA Drugs Consumed in Other
Figure 21. Global ERA Drugs Market: Other (2021-2026) & (K Units)
Figure 22. Global ERA Drugs Sale Market Share by Application (2025)
Figure 23. Global ERA Drugs Revenue Market Share by Application in 2026
Figure 24. ERA Drugs Sales by Company in 2026 (K Units)
Figure 25. Global ERA Drugs Sales Market Share by Company in 2026
Figure 26. ERA Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global ERA Drugs Revenue Market Share by Company in 2026
Figure 28. Global ERA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global ERA Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas ERA Drugs Sales 2021-2026 (K Units)
Figure 31. Americas ERA Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC ERA Drugs Sales 2021-2026 (K Units)
Figure 33. APAC ERA Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe ERA Drugs Sales 2021-2026 (K Units)
Figure 35. Europe ERA Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa ERA Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa ERA Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas ERA Drugs Sales Market Share by Country in 2026
Figure 39. Americas ERA Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas ERA Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas ERA Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC ERA Drugs Sales Market Share by Region in 2026
Figure 47. APAC ERA Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC ERA Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC ERA Drugs Sales Market Share by Application (2021-2026)
Figure 50. China ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe ERA Drugs Sales Market Share by Country in 2026
Figure 58. Europe ERA Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe ERA Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe ERA Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa ERA Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa ERA Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa ERA Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries ERA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of ERA Drugs in 2026
Figure 75. Manufacturing Process Analysis of ERA Drugs
Figure 76. Industry Chain Structure of ERA Drugs
Figure 77. Channels of Distribution
Figure 78. Global ERA Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global ERA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global ERA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global ERA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global ERA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global ERA Drugs Revenue Market Share Forecast by Application (2027-2032)
